Search

Menu

MindSens

About

Rapid, accessible screening for Alzheimer’s Disease Dementia

MindSens offers an innovative, user-friendly blood-based screening device for early detection of Alzheimer’s Disease Dementia (ADD). Designed for home use, it detects biomarkers of brain neuronal damage, providing results in just 15 minutes. This device eliminates the need for costly and invasive methods like MRI or cerebrospinal fluid analysis, enabling regular monitoring by non-specialists. MindSens aims to improve early diagnosis and intervention, reducing the long-term economic and healthcare burden of ADD while enhancing patient outcomes

Trends

# Health 24

Disciplines

# Material Science

Universities

University College London

Rica Asrosa

  • University College London

    Rica Asrosa is an interdisciplinary researcher specializing in Advanced Materials Science and Biosensing. As a co-founder of MindSens, she focuses on developing innovative biosensors and medical devices for healthcare applications, including diabetes, kidney disease, and dementia. With a passion for education and research, Rica aims to translate scientific discoveries into practical solutions that enhance patient care. Her work bridges the gap between laboratory research and real-world healthcare, significantly advancing personalized and preventive medical technologies.more

 Back to overview

Similiar Projects

AiSee

AiSee

National University of Singapore

AI-powered wearable device for real-time visual assistance

AmCURE Antibiotic

AmCURE Antibiotic

Nanyang Technological University

Targeted antimicrobial treatment for resistant infections

ANGIE

ANGIE

ETH Zurich

Magnetically guided microcapsules for brain tumour treatment

Belly Buddy

Belly Buddy

Harvard University

Early detection and non-invasive correction of breech pregnancies